10x Genomics to Present at the Morgan Stanley 20th Annual Global Healthcare Conference

Rhea-AI Summary

10x Genomics (Nasdaq: TXG) announced its participation in the Morgan Stanley 20th Annual Global Healthcare Conference on September 13, 2022, at 10:35 a.m. Eastern Time. The company will engage in a fireside chat, with a live and archived webcast available on its investors' webpage. 10x Genomics, a life sciences technology leader, focuses on products that enhance understanding of biological systems. Their solutions are widely adopted by top global research institutions and pharmaceutical companies, backed by over 1,500 patents and citations in over 3,800 research papers.

PLEASANTON, Calif., Sept. 2, 2022 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a life sciences leader focused on mastering biology to advance human health, today announced the company will be participating in the upcoming Morgan Stanley 20th Annual Global Healthcare Conference in New York, New York.

10x Genomics' management is scheduled to participate in a fireside chat on Tuesday, September 13, at 10:35 a.m. Eastern Time.  Interested parties may access a live and archived webcast of the presentation on the "Investors" section of the company's website at: https://investors.10xgenomics.com/.

About 10x Genomics

10x Genomics is a life science technology company building products to interrogate, understand and master biology to advance human health. Our integrated solutions include instruments, consumables and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. 10x Genomics products have been adopted by researchers around the world including in all of the top 100 global research institutions as ranked by Nature in 2021 based on publications and all of the top 20 global pharmaceutical companies by 2021 research and development spend and have been cited in over 3,800 research papers on discoveries ranging from oncology to immunology and neuroscience. Our patent portfolio comprises more than 1,500 issued patents and patent applications.

Disclosure Information

10x Genomics uses filings with the Securities and Exchange Commission, its website (www.10xgenomics.com), press releases, public conference calls, public webcasts and its social media accounts as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

Contacts 
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-morgan-stanley-20th-annual-global-healthcare-conference-301616861.html

SOURCE 10x Genomics, Inc.

FAQ

When is 10x Genomics presenting at the Morgan Stanley Global Healthcare Conference?

10x Genomics will present on September 13, 2022, at 10:35 a.m. Eastern Time.

How can I access the 10x Genomics presentation from the Morgan Stanley Conference?

The presentation can be accessed through a live and archived webcast on the investors' section of the 10x Genomics website.

What is the focus of 10x Genomics as a life sciences company?

10x Genomics focuses on products that interrogate and understand biological systems to advance human health.

Who are the key clients of 10x Genomics?

10x Genomics products are used by top global research institutions and the leading pharmaceutical companies.

How many patents does 10x Genomics hold?

10x Genomics has over 1,500 issued patents and patent applications.

In how many research papers has 10x Genomics been cited?

10x Genomics has been cited in over 3,800 research papers.